Table of Content

1 Nano-Drug Market Overview
1.1 Product Overview and Scope of Nano-Drug
1.2 Nano-Drug Segment by Type
1.2.1 Global Nano-Drug Market Value Comparison by Type (2024-2034)
1.2.2 Liposomes
1.2.3 Polymeric Micelles
1.2.4 Solid lipid Nanoparticles
1.2.5 Microemulsion and Nanoemulsion
1.2.6 Nanosuspension
1.3 Nano-Drug Segment by Application
1.3.1 Global Nano-Drug Market Value by Application: (2024-2034)
1.3.2 Cancer and Tumors
1.3.3 Autoimmune Disorders
1.4 Global Nano-Drug Market Size Estimates and Forecasts
1.4.1 Global Nano-Drug Revenue 2024-2034
1.4.2 Global Nano-Drug Sales 2024-2034
1.4.3 Global Nano-Drug Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Nano-Drug Market Competition by Manufacturers
2.1 Global Nano-Drug Sales Market Share by Manufacturers (2024-2024)
2.2 Global Nano-Drug Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Nano-Drug Average Price by Manufacturers (2024-2024)
2.4 Global Nano-Drug Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Nano-Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nano-Drug, Product Type & Application
2.7 Nano-Drug Market Competitive Situation and Trends
2.7.1 Nano-Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nano-Drug Players Market Share by Revenue
2.7.3 Global Nano-Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nano-Drug Retrospective Market Scenario by Region
3.1 Global Nano-Drug Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Nano-Drug Global Nano-Drug Sales by Region: 2024-2034
3.2.1 Global Nano-Drug Sales by Region: 2024-2024
3.2.2 Global Nano-Drug Sales by Region: 2024-2034
3.3 Global Nano-Drug Global Nano-Drug Revenue by Region: 2024-2034
3.3.1 Global Nano-Drug Revenue by Region: 2024-2024
3.3.2 Global Nano-Drug Revenue by Region: 2024-2034
3.4 North America Nano-Drug Market Facts & Figures by Country
3.4.1 North America Nano-Drug Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Nano-Drug Sales by Country (2024-2034)
3.4.3 North America Nano-Drug Revenue by Country (2024-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nano-Drug Market Facts & Figures by Country
3.5.1 Europe Nano-Drug Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Nano-Drug Sales by Country (2024-2034)
3.5.3 Europe Nano-Drug Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nano-Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Nano-Drug Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Nano-Drug Sales by Country (2024-2034)
3.6.3 Asia Pacific Nano-Drug Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nano-Drug Market Facts & Figures by Country
3.7.1 Latin America Nano-Drug Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Nano-Drug Sales by Country (2024-2034)
3.7.3 Latin America Nano-Drug Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nano-Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Nano-Drug Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Nano-Drug Sales by Country (2024-2034)
3.8.3 Middle East and Africa Nano-Drug Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Nano-Drug Sales by Type (2024-2034)
4.1.1 Global Nano-Drug Sales by Type (2024-2024)
4.1.2 Global Nano-Drug Sales by Type (2024-2034)
4.1.3 Global Nano-Drug Sales Market Share by Type (2024-2034)
4.2 Global Nano-Drug Revenue by Type (2024-2034)
4.2.1 Global Nano-Drug Revenue by Type (2024-2024)
4.2.2 Global Nano-Drug Revenue by Type (2024-2034)
4.2.3 Global Nano-Drug Revenue Market Share by Type (2024-2034)
4.3 Global Nano-Drug Price by Type (2024-2034)
5 Segment by Application
5.1 Global Nano-Drug Sales by Application (2024-2034)
5.1.1 Global Nano-Drug Sales by Application (2024-2024)
5.1.2 Global Nano-Drug Sales by Application (2024-2034)
5.1.3 Global Nano-Drug Sales Market Share by Application (2024-2034)
5.2 Global Nano-Drug Revenue by Application (2024-2034)
5.2.1 Global Nano-Drug Revenue by Application (2024-2024)
5.2.2 Global Nano-Drug Revenue by Application (2024-2034)
5.2.3 Global Nano-Drug Revenue Market Share by Application (2024-2034)
5.3 Global Nano-Drug Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Merck Nano-Drug Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Pfizer Nano-Drug Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Novartis Nano-Drug Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Abbott
6.4.1 Abbott Corporation Information
6.4.2 Abbott Description and Business Overview
6.4.3 Abbott Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Abbott Nano-Drug Product Portfolio
6.4.5 Abbott Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.5.4 GlaxoSmithKline Nano-Drug Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Roche Nano-Drug Product Portfolio
6.6.5 Roche Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Sanofi Nano-Drug Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Eli Lilly
6.8.1 Eli Lilly Corporation Information
6.8.2 Eli Lilly Description and Business Overview
6.8.3 Eli Lilly Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Eli Lilly Nano-Drug Product Portfolio
6.8.5 Eli Lilly Recent Developments/Updates
6.9 Astrazeneca
6.9.1 Astrazeneca Corporation Information
6.9.2 Astrazeneca Description and Business Overview
6.9.3 Astrazeneca Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Astrazeneca Nano-Drug Product Portfolio
6.9.5 Astrazeneca Recent Developments/Updates
6.10 Johnson & Johnson
6.10.1 Johnson & Johnson Corporation Information
6.10.2 Johnson & Johnson Description and Business Overview
6.10.3 Johnson & Johnson Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Johnson & Johnson Nano-Drug Product Portfolio
6.10.5 Johnson & Johnson Recent Developments/Updates
6.11 Celgene
6.11.1 Celgene Corporation Information
6.11.2 Celgene Nano-Drug Description and Business Overview
6.11.3 Celgene Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Celgene Nano-Drug Product Portfolio
6.11.5 Celgene Recent Developments/Updates
6.12 Novavax
6.12.1 Novavax Corporation Information
6.12.2 Novavax Nano-Drug Description and Business Overview
6.12.3 Novavax Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Novavax Nano-Drug Product Portfolio
6.12.5 Novavax Recent Developments/Updates
6.13 Stryker
6.13.1 Stryker Corporation Information
6.13.2 Stryker Nano-Drug Description and Business Overview
6.13.3 Stryker Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.13.4 Stryker Nano-Drug Product Portfolio
6.13.5 Stryker Recent Developments/Updates
6.14 Gilead Sciences
6.14.1 Gilead Sciences Corporation Information
6.14.2 Gilead Sciences Nano-Drug Description and Business Overview
6.14.3 Gilead Sciences Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Gilead Sciences Nano-Drug Product Portfolio
6.14.5 Gilead Sciences Recent Developments/Updates
6.15 OSI Pharmaceuticals
6.15.1 OSI Pharmaceuticals Corporation Information
6.15.2 OSI Pharmaceuticals Nano-Drug Description and Business Overview
6.15.3 OSI Pharmaceuticals Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.15.4 OSI Pharmaceuticals Nano-Drug Product Portfolio
6.15.5 OSI Pharmaceuticals Recent Developments/Updates
6.16 Kadmon Pharmaceuticals
6.16.1 Kadmon Pharmaceuticals Corporation Information
6.16.2 Kadmon Pharmaceuticals Nano-Drug Description and Business Overview
6.16.3 Kadmon Pharmaceuticals Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.16.4 Kadmon Pharmaceuticals Nano-Drug Product Portfolio
6.16.5 Kadmon Pharmaceuticals Recent Developments/Updates
6.17 Samyang Biopharm
6.17.1 Samyang Biopharm Corporation Information
6.17.2 Samyang Biopharm Nano-Drug Description and Business Overview
6.17.3 Samyang Biopharm Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.17.4 Samyang Biopharm Nano-Drug Product Portfolio
6.17.5 Samyang Biopharm Recent Developments/Updates
6.18 Mitsubishi Pharma
6.18.1 Mitsubishi Pharma Corporation Information
6.18.2 Mitsubishi Pharma Nano-Drug Description and Business Overview
6.18.3 Mitsubishi Pharma Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.18.4 Mitsubishi Pharma Nano-Drug Product Portfolio
6.18.5 Mitsubishi Pharma Recent Developments/Updates
6.19 Kaken Pharmaceutical
6.19.1 Kaken Pharmaceutical Corporation Information
6.19.2 Kaken Pharmaceutical Nano-Drug Description and Business Overview
6.19.3 Kaken Pharmaceutical Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.19.4 Kaken Pharmaceutical Nano-Drug Product Portfolio
6.19.5 Kaken Pharmaceutical Recent Developments/Updates
6.20 Selecta Biosciences
6.20.1 Selecta Biosciences Corporation Information
6.20.2 Selecta Biosciences Nano-Drug Description and Business Overview
6.20.3 Selecta Biosciences Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.20.4 Selecta Biosciences Nano-Drug Product Portfolio
6.20.5 Selecta Biosciences Recent Developments/Updates
6.21 Par Pharmaceutical
6.21.1 Par Pharmaceutical Corporation Information
6.21.2 Par Pharmaceutical Nano-Drug Description and Business Overview
6.21.3 Par Pharmaceutical Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.21.4 Par Pharmaceutical Nano-Drug Product Portfolio
6.21.5 Par Pharmaceutical Recent Developments/Updates
6.22 Cerulean Pharma
6.22.1 Cerulean Pharma Corporation Information
6.22.2 Cerulean Pharma Nano-Drug Description and Business Overview
6.22.3 Cerulean Pharma Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.22.4 Cerulean Pharma Nano-Drug Product Portfolio
6.22.5 Cerulean Pharma Recent Developments/Updates
6.23 Navidea Biopharmaceuticals
6.23.1 Navidea Biopharmaceuticals Corporation Information
6.23.2 Navidea Biopharmaceuticals Nano-Drug Description and Business Overview
6.23.3 Navidea Biopharmaceuticals Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.23.4 Navidea Biopharmaceuticals Nano-Drug Product Portfolio
6.23.5 Navidea Biopharmaceuticals Recent Developments/Updates
6.24 Lummy
6.24.1 Lummy Corporation Information
6.24.2 Lummy Nano-Drug Description and Business Overview
6.24.3 Lummy Nano-Drug Sales, Revenue and Gross Margin (2024-2024)
6.24.4 Lummy Nano-Drug Product Portfolio
6.24.5 Lummy Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nano-Drug Industry Chain Analysis
7.2 Nano-Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nano-Drug Production Mode & Process
7.4 Nano-Drug Sales and Marketing
7.4.1 Nano-Drug Sales Channels
7.4.2 Nano-Drug Distributors
7.5 Nano-Drug Customers
8 Nano-Drug Market Dynamics
8.1 Nano-Drug Industry Trends
8.2 Nano-Drug Market Drivers
8.3 Nano-Drug Market Challenges
8.4 Nano-Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Nano-Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Nano-Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Nano-Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Nano-Drug Sales (K Doses) of Key Manufacturers (2024-2024)
Table 5. Global Nano-Drug Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Nano-Drug Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Nano-Drug Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Nano-Drug Average Price (USD/Dose) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Nano-Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Nano-Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nano-Drug, Product Type & Application
Table 12. Global Key Manufacturers of Nano-Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nano-Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nano-Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nano-Drug Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Nano-Drug Sales by Region (2024-2024) & (K Doses)
Table 18. Global Nano-Drug Sales Market Share by Region (2024-2024)
Table 19. Global Nano-Drug Sales by Region (2024-2034) & (K Doses)
Table 20. Global Nano-Drug Sales Market Share by Region (2024-2034)
Table 21. Global Nano-Drug Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Nano-Drug Revenue Market Share by Region (2024-2024)
Table 23. Global Nano-Drug Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Nano-Drug Revenue Market Share by Region (2024-2034)
Table 25. North America Nano-Drug Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Nano-Drug Sales by Country (2024-2024) & (K Doses)
Table 27. North America Nano-Drug Sales by Country (2024-2034) & (K Doses)
Table 28. North America Nano-Drug Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Nano-Drug Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Nano-Drug Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Nano-Drug Sales by Country (2024-2024) & (K Doses)
Table 32. Europe Nano-Drug Sales by Country (2024-2034) & (K Doses)
Table 33. Europe Nano-Drug Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Nano-Drug Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Nano-Drug Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Nano-Drug Sales by Region (2024-2024) & (K Doses)
Table 37. Asia Pacific Nano-Drug Sales by Region (2024-2034) & (K Doses)
Table 38. Asia Pacific Nano-Drug Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Nano-Drug Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Nano-Drug Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Nano-Drug Sales by Country (2024-2024) & (K Doses)
Table 42. Latin America Nano-Drug Sales by Country (2024-2034) & (K Doses)
Table 43. Latin America Nano-Drug Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Nano-Drug Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Nano-Drug Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Nano-Drug Sales by Country (2024-2024) & (K Doses)
Table 47. Middle East & Africa Nano-Drug Sales by Country (2024-2034) & (K Doses)
Table 48. Middle East & Africa Nano-Drug Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Nano-Drug Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Nano-Drug Sales (K Doses) by Type (2024-2024)
Table 51. Global Nano-Drug Sales (K Doses) by Type (2024-2034)
Table 52. Global Nano-Drug Sales Market Share by Type (2024-2024)
Table 53. Global Nano-Drug Sales Market Share by Type (2024-2034)
Table 54. Global Nano-Drug Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Nano-Drug Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Nano-Drug Revenue Market Share by Type (2024-2024)
Table 57. Global Nano-Drug Revenue Market Share by Type (2024-2034)
Table 58. Global Nano-Drug Price (USD/Dose) by Type (2024-2024)
Table 59. Global Nano-Drug Price (USD/Dose) by Type (2024-2034)
Table 60. Global Nano-Drug Sales (K Doses) by Application (2024-2024)
Table 61. Global Nano-Drug Sales (K Doses) by Application (2024-2034)
Table 62. Global Nano-Drug Sales Market Share by Application (2024-2024)
Table 63. Global Nano-Drug Sales Market Share by Application (2024-2034)
Table 64. Global Nano-Drug Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Nano-Drug Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Nano-Drug Revenue Market Share by Application (2024-2024)
Table 67. Global Nano-Drug Revenue Market Share by Application (2024-2034)
Table 68. Global Nano-Drug Price (USD/Dose) by Application (2024-2024)
Table 69. Global Nano-Drug Price (USD/Dose) by Application (2024-2034)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 73. Merck Nano-Drug Product
Table 74. Merck Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 78. Pfizer Nano-Drug Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 83. Novartis Nano-Drug Product
Table 84. Novartis Recent Developments/Updates
Table 85. Abbott Corporation Information
Table 86. Abbott Description and Business Overview
Table 87. Abbott Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 88. Abbott Nano-Drug Product
Table 89. Abbott Recent Developments/Updates
Table 90. GlaxoSmithKline Corporation Information
Table 91. GlaxoSmithKline Description and Business Overview
Table 92. GlaxoSmithKline Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 93. GlaxoSmithKline Nano-Drug Product
Table 94. GlaxoSmithKline Recent Developments/Updates
Table 95. Roche Corporation Information
Table 96. Roche Description and Business Overview
Table 97. Roche Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 98. Roche Nano-Drug Product
Table 99. Roche Recent Developments/Updates
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 103. Sanofi Nano-Drug Product
Table 104. Sanofi Recent Developments/Updates
Table 105. Eli Lilly Corporation Information
Table 106. Eli Lilly Description and Business Overview
Table 107. Eli Lilly Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 108. Eli Lilly Nano-Drug Product
Table 109. Eli Lilly Recent Developments/Updates
Table 110. Astrazeneca Corporation Information
Table 111. Astrazeneca Description and Business Overview
Table 112. Astrazeneca Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 113. Astrazeneca Nano-Drug Product
Table 114. Astrazeneca Recent Developments/Updates
Table 115. Johnson & Johnson Corporation Information
Table 116. Johnson & Johnson Description and Business Overview
Table 117. Johnson & Johnson Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 118. Johnson & Johnson Nano-Drug Product
Table 119. Johnson & Johnson Recent Developments/Updates
Table 120. Celgene Corporation Information
Table 121. Celgene Description and Business Overview
Table 122. Celgene Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 123. Celgene Nano-Drug Product
Table 124. Celgene Recent Developments/Updates
Table 125. Novavax Corporation Information
Table 126. Novavax Description and Business Overview
Table 127. Novavax Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 128. Novavax Nano-Drug Product
Table 129. Novavax Recent Developments/Updates
Table 130. Stryker Corporation Information
Table 131. Stryker Description and Business Overview
Table 132. Stryker Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 133. Stryker Nano-Drug Product
Table 134. Stryker Recent Developments/Updates
Table 135. Gilead Sciences Corporation Information
Table 136. Gilead Sciences Description and Business Overview
Table 137. Gilead Sciences Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 138. Gilead Sciences Nano-Drug Product
Table 139. Gilead Sciences Recent Developments/Updates
Table 140. OSI Pharmaceuticals Corporation Information
Table 141. OSI Pharmaceuticals Description and Business Overview
Table 142. OSI Pharmaceuticals Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 143. OSI Pharmaceuticals Nano-Drug Product
Table 144. OSI Pharmaceuticals Recent Developments/Updates
Table 145. Kadmon Pharmaceuticals Corporation Information
Table 146. Kadmon Pharmaceuticals Description and Business Overview
Table 147. Kadmon Pharmaceuticals Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 148. Kadmon Pharmaceuticals Nano-Drug Product
Table 149. Kadmon Pharmaceuticals Recent Developments/Updates
Table 150. Samyang Biopharm Corporation Information
Table 151. Samyang Biopharm Description and Business Overview
Table 152. Samyang Biopharm Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 153. Samyang Biopharm Nano-Drug Product
Table 154. Samyang Biopharm Recent Developments/Updates
Table 155. Mitsubishi Pharma Corporation Information
Table 156. Mitsubishi Pharma Description and Business Overview
Table 157. Mitsubishi Pharma Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 158. Mitsubishi Pharma Nano-Drug Product
Table 159. Mitsubishi Pharma Recent Developments/Updates
Table 160. Kaken Pharmaceutical Corporation Information
Table 161. Kaken Pharmaceutical Description and Business Overview
Table 162. Kaken Pharmaceutical Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 163. Kaken Pharmaceutical Nano-Drug Product
Table 164. Kaken Pharmaceutical Recent Developments/Updates
Table 165. Selecta Biosciences Corporation Information
Table 166. Selecta Biosciences Description and Business Overview
Table 167. Selecta Biosciences Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 168. Selecta Biosciences Nano-Drug Product
Table 169. Selecta Biosciences Recent Developments/Updates
Table 170. Par Pharmaceutical Corporation Information
Table 171. Par Pharmaceutical Description and Business Overview
Table 172. Par Pharmaceutical Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 173. Par Pharmaceutical Nano-Drug Product
Table 174. Par Pharmaceutical Recent Developments/Updates
Table 175. Cerulean Pharma Corporation Information
Table 176. Cerulean Pharma Description and Business Overview
Table 177. Cerulean Pharma Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 178. Cerulean Pharma Nano-Drug Product
Table 179. Cerulean Pharma Recent Developments/Updates
Table 180. Navidea Biopharmaceuticals Corporation Information
Table 181. Navidea Biopharmaceuticals Description and Business Overview
Table 182. Navidea Biopharmaceuticals Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 183. Navidea Biopharmaceuticals Nano-Drug Product
Table 184. Navidea Biopharmaceuticals Recent Developments/Updates
Table 185. Lummy Corporation Information
Table 186. Lummy Description and Business Overview
Table 187. Lummy Nano-Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 188. Lummy Nano-Drug Product
Table 189. Lummy Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Nano-Drug Distributors List
Table 193. Nano-Drug Customers List
Table 194. Nano-Drug Market Trends
Table 195. Nano-Drug Market Drivers
Table 196. Nano-Drug Market Challenges
Table 197. Nano-Drug Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nano-Drug
Figure 2. Global Nano-Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Nano-Drug Market Share by Type in 2022 & 2034
Figure 4. Liposomes Product Picture
Figure 5. Polymeric Micelles Product Picture
Figure 6. Solid lipid Nanoparticles Product Picture
Figure 7. Microemulsion and Nanoemulsion Product Picture
Figure 8. Nanosuspension Product Picture
Figure 9. Global Nano-Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Nano-Drug Market Share by Application in 2022 & 2034
Figure 11. Cancer and Tumors
Figure 12. Autoimmune Disorders
Figure 13. Global Nano-Drug Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 14. Global Nano-Drug Market Size (2024-2034) & (US$ Million)
Figure 15. Global Nano-Drug Sales (2024-2034) & (K Doses)
Figure 16. Global Nano-Drug Average Price (USD/Dose) & (2024-2034)
Figure 17. Nano-Drug Report Years Considered
Figure 18. Nano-Drug Sales Share by Manufacturers in 2022
Figure 19. Global Nano-Drug Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Nano-Drug Players: Market Share by Revenue in 2022
Figure 21. Nano-Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 22. Global Nano-Drug Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 23. North America Nano-Drug Sales Market Share by Country (2024-2034)
Figure 24. North America Nano-Drug Revenue Market Share by Country (2024-2034)
Figure 25. U.S. Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 26. Canada Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 27. Europe Nano-Drug Sales Market Share by Country (2024-2034)
Figure 28. Europe Nano-Drug Revenue Market Share by Country (2024-2034)
Figure 29. Germany Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. France Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. U.K. Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. Italy Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Russia Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Asia Pacific Nano-Drug Sales Market Share by Region (2024-2034)
Figure 35. Asia Pacific Nano-Drug Revenue Market Share by Region (2024-2034)
Figure 36. China Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. Japan Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. South Korea Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. India Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. Australia Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Taiwan Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. Indonesia Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Thailand Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Malaysia Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Philippines Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Latin America Nano-Drug Sales Market Share by Country (2024-2034)
Figure 47. Latin America Nano-Drug Revenue Market Share by Country (2024-2034)
Figure 48. Mexico Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Brazil Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Argentina Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. Middle East & Africa Nano-Drug Sales Market Share by Country (2024-2034)
Figure 52. Middle East & Africa Nano-Drug Revenue Market Share by Country (2024-2034)
Figure 53. Turkey Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 54. Saudi Arabia Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 55. U.A.E Nano-Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 56. Global Sales Market Share of Nano-Drug by Type (2024-2034)
Figure 57. Global Revenue Market Share of Nano-Drug by Type (2024-2034)
Figure 58. Global Nano-Drug Price (USD/Dose) by Type (2024-2034)
Figure 59. Global Sales Market Share of Nano-Drug by Application (2024-2034)
Figure 60. Global Revenue Market Share of Nano-Drug by Application (2024-2034)
Figure 61. Global Nano-Drug Price (USD/Dose) by Application (2024-2034)
Figure 62. Nano-Drug Value Chain
Figure 63. Nano-Drug Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed